Science Exchange’s Post

Learn how to ensure reproducibility in research using human pluripotent stem cell models in this Science Exchange article: https://bit.ly/3VC6vg6

#ArticleoftheWeek published by ScienceDirect.com Exciting advancements in #iPSC research for clinical applications! A new guide has been published, providing valuable insights into the clinical application of induced pluripotent stem cells (#iPSCs). The authors emphasize the critical importance of well-established workflows to ensure consistency and reliability in #research and #therapeutic use. Quality matters! The guide highlights that the quality of the starting material is paramount for successful outcomes in iPSC-based #treatments. For those in the field, this guide is a must-read to stay at the forefront of #iPSCresearch and its clinical #applications. Read the full article here: https://lnkd.in/eDnHNrQm Congratulations to: Hannah W. Song , Jennifer Solomon, Kapil Bharti, Amanda Mack Nisha Durand, Ph.D, Emmanuelle Cameau, Diana Patzelt, PhD, Arwen Hunter, PhD Gary Soh, Brianna Schoen, Matthew Marsh, Christopher Bravery, Cenk Sumen, Dominic Clarke, Uma Lakshmipathy, Julie G. Allickson, PhD #iPSC #StemCells #ClinicalResearch #Biotechnology #HealthcareInnovation

Researchers use stem cells to grow organoids—3D miniature organs—in cell culture. They use these to gain insight into organ development and disease and to screen new drug therapies. As new technologies emerge, scientists produce increasingly complex organoids that mimic human tissues more closely. As they do so, they step into new medical research frontiers that have the potential to revolutionize human health. Learn how researchers use the latest technology to create and validate organoids and use them to answer a wide range of research questions in this new poster sponsored by Tecan. Download the poster here: https://ow.ly/zBRW50Qoo2a

BREAKING NEWS! HBRF is thrilled to share our latest peer-reviewed publication in Frontiers in Medicine, entitled “Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID-19: a randomized controlled trial.” This is HBRF’s second peer-reviewed piece on work in COVID, and demonstrates that even an acute population found the intervention safe and tolerable. Read the manuscript at https://lnkd.in/gRU_Yix8 #covid #covid19 #clinicalresearch #celltherapy #biotech #published

Want to unlock the potential of mesenchymal stem cells (MSCs)? In our latest blog, we explore MSC sources, characteristics, and their promising role in regenerative medicine. We also discuss how these multipotent cells can differentiate into various tissue types and why proper characterization is crucial. Learn more about MSCs: <<https://lnkd.in/erG-6APR>> #stemcells #cellculture

Excited to advertise an upcoming webinar hosted by Proteintech! REGISTER NOW by clicking on the post. Curious about iPSCs? Are you a stem cell biologist just gearing up to start culturing those iPSCs? This webinar is for you to get ahead of the game and get some quick tips from one of the experts in the field, Dr. Max Friesen from the Whitehead Institute at MIT. Get a quick and informative insight into what it's like to to culture induced pluripotent stem cells. You do not need to be a stem cell biology expert to join this webinar. If you are curious to what iPSC technologies can contribute to the world of science? Hop into our webinar! Don't need basic advice but need to ask a question to the speaker about more complex iPSC questions? Join the live Q&A! See you there! #stemcells #iPSCs #inducedpluripotentstemcells

It's the last day to learn how to increase stem cell reprogramming and differentiation efficiency and homogeneity at #SfN2024! Stop by booth 1305 to pick up your copy of the scientific poster "Accelerating the Use of Patient-Derived hiPSC Neuronal Models by Increasing Efficiency of Reprogramming and Differentiation Using CellRaft Technology." https://hubs.la/Q02RSd4L0 #stemcells #diseasemodels #biomedical

Want to unlock the potential of mesenchymal stem cells (MSCs)?

Exosome therapy is an emerging area of regenerative medicine that harnesses the therapeutic potential of exosomes, small extracellular vesicles released by cells. Exosomes play a crucial role in intercellular communication by transferring various biomolecules, including proteins, lipids, and nucleic acids, between cells. They are involved in regulating physiological processes such as immune response, tissue repair, and cell proliferation. Exosome therapy involves isolating exosomes from donor cells, often stem cells or other types of regenerative cells, and administering them to recipients to promote tissue repair and regeneration. Visit us for more information : https://lnkd.in/gHHWFg4m Submissions are Open in the broad scope of the Journal of Regenerative Biology and Medicine [ISSN: 2582-385X]. Authors can directly submit their manuscripts to regenerativeBiol@maplejournal.com Source: Internet. #tissues #regeneration #research #regenerativemedicine #exosometherapy